期刊文献+

多巴胺及去甲肾上腺素对感染性休克患者血流动力学和组织氧代谢的影响 被引量:8

下载PDF
导出
摘要 目的:探究分析多巴胺和去甲肾上腺素对感染性休克患者血流动力学和组织氧代谢的影响,以期为提高感染性休克患者的临床疗效提供有效依据。方法:选取自2011年7月至2013年1月在我院接受治疗的感染性休克患者120例,采取随机数字表法将其分为观察组与对照组,对照组患者予以多巴胺治疗,观察组患者予以去甲肾上腺素进行治疗,比较两组患者血流动力学和组织氧代谢情况,完善有关资料的记录工作。结果:采取对照治疗后,两组患者临床症状均有所改善,比较血流动力学指标发现,观察组患者心率和心排出量显著低于对照组,而外周血管阻力指数则显著高于对照组,P<0.05;而且比较组织氧代谢情况,观察组患者乳酸清除率和混合静脉血氧饱和度均高于对照组,P<0.05,均具有统计学意义。结论:临床应用去甲肾上腺素进行感染性休克的治疗,可以更好的改善患者血流动力学指标和组织氧代谢情况,值得临床推广。
作者 姜福富
出处 《求医问药(下半月)》 2013年第6期103-104,共2页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献6

二级参考文献25

  • 1高景利,李晓岚,王爱田.比较多巴胺与去甲肾上腺素对感染性休克血流动力学和氧代谢的影响[J].疑难病杂志,2008,7(7):390-393. 被引量:10
  • 2邱海波,杨毅,刘松桥.《2004严重感染和感染性休克治疗指南》系列讲座(2) 严重感染和感染性休克的容量复苏和血管活性药物应用[J].中国危重病急救医学,2004,16(8):451-453. 被引量:110
  • 3阎明,孟繁立.肝硬化肝肾综合征的治疗[J].中华肝脏病杂志,2005,13(6):458-458. 被引量:14
  • 4Gines P,Guevara M,Arroyo V, et al. Hepatorenal syndrome[J]. Lancet, 2003,362: 1819 - 1827.
  • 5Arroyo V, Gines P, Gerbes A, et al. Definiti on and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International aseiles clubs [JJ. Hepatology, 1996, 23: 164 - 173.
  • 6Restuccia T, Guevara M, Gines P, et al. Effects of treatment of hepatorenal syndrome before transplantalion on posttransplatation outcome: A case- control study [ J ]. J Hepatol, 2004, 40 (1) : 140: 146.
  • 7Moreau R. The growing evidence that renal function should be improved in patients with cirrhosis and hepatorenal syndrome before liver transplantation [J]. J Hepatol, 2004, 40: 159-161.
  • 8Romson JL, Leung JM, Bellows WH, et al.Effects of dobutamine on he- modynamics and left ventricular performance after cardiopulmonary by-pess in cardiac surgical patient[J].Anesthesiology, 1999i91(5): 1318-1328.
  • 9Vincent J L,van der Linden P.Septic shock:particular type of acute circulatory failure[J].Crit Care Med,1990,18(1 Pt 2):S70-74.
  • 10Mizock B A,Falk J L.Lactic acidosis in critical illness[J].Crit Care Med,2004,20(1):80-91.

共引文献68

同被引文献63

  • 1Tsuda Y,Kobayashi M,Herndon DN,et al.Impairment of the host's antibacterial resistance by norepinephrine activated neutrophils[J].Burns,2008,34 (4):460-466.
  • 2Robinson K, Kruger P, Prins J, et al. The metabolic syndrome in critical ill patients. Best Pract Res Clin Endocrinol Metab,2011,25:835-$45.
  • 3Suarez-Santamaria M, Santolaria F, Perez-Ramirez A. Prognostic value of inflammatory markers ( notably cytokines and procalcitonin ), nutritional assessment, and organ function in patients with sepsis. Eur Cytokine Netw,2010,21 : 19-24.
  • 4Tschaikowsky K, Hedwig-Geissing M, Braun GG, et al. Predietive value of procalcitonin, interleukiu-6, and C-reactive protein for survival in postop- erative patients with severe sepsis. J Crit Care,2011,1:195-200.
  • 5Andert SE, Griesmacher A, Zuckcrmann A, et al. Neopterin release from human endothelial cells is triggered by interferon-gamma. Clin Exp Immu- nol,2012,88:555-558.
  • 6Bevilacqua M. Endothelial leukocyte adhesion molecules. Annu Rev Im- munol, 1993,11:767-804.
  • 7Butter T,Weyers S,Postert T,et al. S100 protein:serum marker of focal brain damage after ischemie territorial MCA infarction. Stroke, 2011, 28 : 1961-1965.
  • 8Jiang JY,Gao GY,Li WP,et al. Early indicators of prognosis in 846 of severe traumatic brain injury. Neurotruma,2012,19:869-874.
  • 9Carr AC,Shaw GM,Fowler AA,et al.Ascorbate-dependent vasopressor synthesis:a rationale for vitamin C administration in severe sepsis and septic shock?[J].Crit Care,2015,19:418.
  • 10Du Y,Wang L,Shi H,et al.Comparison of clinical effect of dopamine and norepinephrine in the treatment of septic shock[J].Pak J Pharm Sci,2015,28(4 Suppl):1461-1464.

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部